Authors
Loading...
Review highlights α-glucosidase inhibitors improve blood glucose levels in type 2 diabetes, suggesting 1,2,4-triazole agents as promising alternatives.
Hamada S. Abulkhair (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: